Donor identification and consent for deceased organ donation: summary of NICE guidance
Subjectsartificial and donated transplantation
end of life decisions
coma and raised intracranial pressure
health service research
pancreas and biliary tract
MetadataShow full item record
AbstractOrgan donation plays a major role in the management of patients with single organ failure of the kidneys, liver, pancreas, heart, or lung, or with combined organ failure of heart and lung (such as in cystic fibrosis) or of kidney and pancreas (such as in diabetes). A shortage of transplant organs has resulted in long waits for transplantation. Currently about 500 people in the United Kingdom die each year because of a shortage of donated organs, and at 31 March 2011 almost 7000 patients were waiting for a kidney transplant1 and would be having costly dialysis with serious morbidity and impact on quality of life. This shortage of organs is partly the result of relatively low numbers of road traffic deaths (lower than in many countries) but is also the result of inefficiencies in the donor identification and consent processes. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on improving donor identification and consent rates for deceased organ donation.
CitationChamberlain, K., Baker, M., Kandaswamy, P., Shaw, E., McVeigh, G., Siddiqui, F. and Randhawa, G. (2012) 'Donor identification and consent for deceased organ donation: Summary of NICE guidance', British Medical Journal, 344 , pp.e341.